Hook & thesis
Lockheed Martin ($503.60) looks actionable here. The stock has pulled back from its 52-week high of $692 to the low-$400s earlier this year, leaving a forward-looking opportunity: missile-related revenue growth (MFC) plus margin recovery across the portfolio could materially lift earnings per share and prompt a re-rating. Given the company's scale, free cash flow generation and dividend, this is a trade where earnings and margin signals do the heavy lifting for price appreciation.
My trade thesis: buy LMT at a tactical entry and hold for fundamental confirmation tied to contract awards and margin improvement. If management’s operating leverage under current backlog and MFC tailwinds shows through in reported margins, the market will likely price in higher forward multiples — pushing the stock toward $580 over a 180 trading-day horizon.
What the company does and why the market should care
Lockheed Martin is a global aerospace and defense prime operating four core segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The MFC segment covers tactical missiles, air-to-ground precision strikes and air & missile defense systems — areas seeing elevated defense budgets and procurement urgency. That makes MFC a high-margin, high-growth pocket inside a mature prime contractor.
The market should care because modest margin inflection in MFC and execution-related improvements across RMS and Space magnify EPS at a company with substantial buybacks and high return on equity. Free cash flow is robust: free cash flow last reported at $8.73B and enterprise value sits around $131.96B, leaving room for reinvestment, dividends and continued shareholder returns.
Numbers that matter
- Current price: $503.60 (intraday snapshot).
- Market capitalization: roughly $116.2B.
- Trailing earnings per share (EPS): about $27.24; consensus and research commentary point to FY EPS rising toward $30.45 in analyst projections (reported commentary on 10/07/2026 signals full-year upgrades).
- Valuation: P/E around 18-19 and price-to-sales ~1.5; EV/EBITDA ~12.2.
- Free cash flow: $8.73B; dividend per share: $3.45 with a yield roughly 2.7%.
- Balance sheet & returns: debt-to-equity ~2.34, return on equity ~71.7% (reflecting capital returns and leverage), return on assets ~10.1%.
- Technicals: 10-day SMA ~$509, 50-day SMA ~$550, RSI ~34.7 (near the lower end), MACD showing bearish momentum but with short interest days-to-cover ~2-3 days — manageable short squeeze risk.
Valuation framing
At a market cap near $116B and a current P/E in the high teens, Lockheed is not expensive for a defense prime with double-digit FCF. Recent research notes a forward P/E in the mid-teens versus an industry average above 21 (research commentary on 10/06/2026). That suggests room for a multiple expansion if earnings expectations move materially north due to MFC growth and margin recovery.
Put differently: if EPS drifts to the low $30s (consensus chatter toward $30.45) and the market assigns a P/E of ~19-19.5 (still below peak historical levels but above today’s), valuation mathematically supports a mid-$500s to low-$600s price — consistent with a $580 target for this trade plan.
Catalysts (what to watch)
- Contract awards and modifications in MFC and Space (example: Navy electronic warfare awards, reported 10/06/2026) that expand backlog or push near-term revenue.
- Quarterly margin disclosures showing improving gross and operating margins in MFC and RMS versus the prior year.
- Guidance/consensus revisions around FY EPS, especially any upgrades toward ~$30+ per share in analyst models (commentary on 10/07/2026 already flags FY EPS revision potential).
- Free cash flow trajectory and capital allocation announcements (buybacks/dividend increases) that demonstrate shareholder-friendly deployment of excess cash.
Trade plan (actionable)
| Action | Price | Horizon | Rationale |
|---|---|---|---|
| Entry | $504.00 | Long term (180 trading days) | Near current levels; capture upside if margin recovery and MFC contract wins accelerate earnings. |
| Target | $580.00 | Reflects EPS ~ $30+ and a modest re-rating to mid-to-high teens P/E. | |
| Stop loss | $470.00 | Protects capital if execution or margin recovery stalls; break of $470 would signal downside momentum and potential guidance misses. |
Why 180 trading days? Margin recovery and sizable contract ramp-ups are multi-quarter stories. This horizon gives time for 1-2 quarterly reports to show concrete execution and for the market to re-rate the stock.
Risks and counterarguments
Here are the primary risks that could derail the thesis:
- Execution risk - Lockheed's book of complex programs can carry schedule and cost overrun risk. If margins remain pressured due to program execution issues, EPS upside evaporates.
- Budget & procurement shifts - A change in U.S. defense procurement priorities or sequestration-like pressures could slow MFC contract awards or deliveries.
- Balance sheet leverage - Debt-to-equity around 2.34 implies meaningful leverage; if interest costs rise further or cash flow weakens, capital returns and buybacks could be curtailed.
- Macroeconomic/market risk - A broad multiple compression in equities or risk-off in cyclicals could compress LMT even if fundamentals hold steady.
- Sentiment & technical risk - Current technicals show downward momentum; if sentiment deteriorates (higher shorting or selling flows) the stock could retest prior lows near $437.
Counterargument: One reasonable counter is that Lockheed already prices in the defense premium and that a structurally lower multiple is warranted given higher leverage and program risk. If EPS does not climb into the low $30s, a re-rating to the mid-teens P/E will not materialize and the stock could remain range-bound or drift lower. That scenario argues for patience or a more conservative target.
What would change my mind
I will reduce conviction if quarterly reports show persistent margin compression in MFC or RMS, organic order flow weakens, or management alters capital allocation away from buybacks/dividends due to cash constraints. Conversely, an acceleration in backlog growth, margin beats and an upgraded EPS guide would increase conviction and could justify tightening the stop and raising the target.
Bottom line
Lockheed Martin presents a tradeable long where a modest multiple expansion, driven by MFC momentum and margin recovery, supports upside to $580 over the next 180 trading days. The company’s strong free cash flow and dividend underpin downside protection, but execution, budget risk and leverage are real and justify a $470 stop. This is a fundamentally-backed, event-driven trade: buy at $504.00, stop $470.00, target $580.00, and reevaluate around upcoming quarterly results and material contract announcements.
Key near-dates to watch: contract announcements and the next quarterly report cycle for margin and backlog confirmation (watch for press releases and management commentary around dates in October and the following quarter).